General Information of the Compound
| Compound ID |
CP0049408
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
Anturan
Show/Hide
|
||||||||||||||||||
| Synonyms |
(+/-)-SULFINPYRAZONE
1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin
1,2-Diphenyl-3,5-dioxo-4-(2'-phenyl-sulfinyl-aethyl)-pyrazolidin [German]
1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl) pyrazolidine
1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine
1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione
1,2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)-3,5-pyrazolidinedione
1,2-Diphenyl-4-(phenylsulfinylethyl)-3,5-pyrazolidinedione
1,2-Diphenyl-4-[2-(phenylsulfinyl)ethyl-3,5-pyrazolidinedione
1,2-diphenyl-4-[2-(phenylsulfinyl)ethyl]pyrazolidine-3,5-dione
4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione
4-(Phenylsulfoxyethyl)-1,2-diphenyl-3,5-pyrazolidinedione
4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione
Anturan
Anturane
Anturane (TN)
Anturanil
Anturano
Anturen
Anturidin
Apo Sulfinpyrazone
Apo-Sulfinpyrazone
Apotex Brand of Sulfinpyrazone
Diphenylpyrazone
Enturan
Enturen
G 28,315
G 28315
Novartis Brand of Sulfinpyrazone
Novopyrazone
Nu Pharm Brand of Sulfinpyrazone
Nu Sulfinpyrazone
Nu-Pharm Brand of Sulfinpyrazone
Nu-Sulfinpyrazone
Sulfinpirazona
Sulfinpirazona [INN-Spanish]
Sulfinpyrazine
Sulfinpyrazon
Sulfinpyrazone
Sulfinpyrazone (JP15/USP/INN)
Sulfinpyrazone (SPZ)
Sulfinpyrazone [USAN:INN:JAN]
Sulfinpyrazonum
Sulfinpyrazonum [INN-Latin]
Sulfoxyphenylpyrazolidin
Sulfoxyphenylpyrazolidine
Sulphinpyrazone
USAF GE-13
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H20N2O3S
|
||||||||||||||||||
| Molecular Weight |
404.491
|
||||||||||||||||||
| Canonical SMILES |
[O-][S+](CCC1C(=O)N(N(C1=O)c1ccccc1)c1ccccc1)c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
MBGGBVCUIVRRBF-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
57-96-5
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Clinical Information about the Compound